Target intelligence / Profile preview

Ribosomal protein S2 pseudogene 36 (RPS2P36)

Target
RPS2P36
Molecular classification
Other (Processed pseudogene)
01

Overview

Ribosomal protein S2 pseudogene 36 (RPS2P36) is a **processed pseudogene** derived from the ribosomal protein S2 gene (RPS2)[5]. Pseudogenes such as RPS2P36 are non-functional remnants of protein-coding genes generated through retrotransposition or duplication events. While the parent RPS2 gene encodes a component of the small 40S ribosomal subunit and plays a role in protein synthesis[2][3][6], RPS2P36 itself does not encode a functional protein, has no known biological activity, and is dispersed in the genome among many other ribosomal pseudogenes as part of normal genomic architecture[5]. There is no evidence for a role of RPS2P36 in human disease, drug interactions, or therapeutic targeting. In summary, RPS2P36 is a **genomic pseudogene**, not a functional biological target. It does not fulfill criteria for molecular classification, function, or drug targeting—queries regarding its role as a receptor, enzyme, or disease gene are incorrect in the context of current scientific understanding[5][2][3][6].

Other names
RPS2_13_1085RPS2P36
02

Mechanism of action

None (Pseudogenes do not have mechanisms of action in drug pharmacology)

03

Biological functions

Other (No known biological function; pseudogenes are generally non-coding[5])
04

Disease associations

Other (No known direct disease roles; the parent RPS2 gene is implicated in Diamond-Blackfan anemia, but pseudogenes themselves are not functional and do not have associated disease roles[3][5])
05

Safety considerations

None (No documented safety concerns or therapeutic challenges directly related to ribosomal pseudogenes)
06

Interacting drugs

None (No drugs known or expected to interact with processed ribosomal pseudogenes)
07

Biomarkers

None (Not used as a biomarker for patient selection or efficacy monitoring in current clinical or research practice)

Beyond the preview

Go deeper on Ribosomal protein S2 pseudogene 36 (RPS2P36).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S2 pseudogene 36 (RPS2P36).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call